These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6982394

  • 1. Biochemical and cell cycle perturbations in methotrexate-treated cells.
    Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.
    Mol Pharmacol; 1982 Jan; 21(1):204-10. PubMed ID: 6982394
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
    Taylor IW, Tattersall MH.
    Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
    [Abstract] [Full Text] [Related]

  • 3. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
    Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.
    Cancer Res; 1982 Dec; 42(12):5159-64. PubMed ID: 6958362
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ, Otten M, Grindey GB.
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [Abstract] [Full Text] [Related]

  • 5. Effects of extracellular purines on cytotoxicity of methotrexate.
    Chong L, Ma G, Bartier WA, Tattersall MH.
    Cancer Chemother Pharmacol; 2010 May; 66(1):121-7. PubMed ID: 19784836
    [Abstract] [Full Text] [Related]

  • 6. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D, Peck C.
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.
    Kwok JB, Tattersall MH.
    Br J Cancer; 1992 Apr; 65(4):503-8. PubMed ID: 1562458
    [Abstract] [Full Text] [Related]

  • 9. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P, Calabresi P, Goulette FA, Renaud CA, Darnowski JW.
    Cancer Res; 1992 Aug 01; 52(15):4069-73. PubMed ID: 1638518
    [Abstract] [Full Text] [Related]

  • 10. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ, Estlin EJ, Taylor GA, Aherne GW, Hardcastle A, McGuire JJ, Calvete JA, Lunec J, Pearson AD, Newell DR.
    Clin Cancer Res; 1999 Sep 01; 5(9):2548-58. PubMed ID: 10499632
    [Abstract] [Full Text] [Related]

  • 11. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M, Niwa M, Katano N, Fujimoto T.
    Cancer Res; 1988 Aug 01; 48(15):4288-93. PubMed ID: 3390825
    [Abstract] [Full Text] [Related]

  • 12. Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate.
    Mordoh J, Chacón RD, Filmus J.
    Cancer Res; 1981 Sep 01; 41(9 Pt 1):3621-8. PubMed ID: 6942915
    [Abstract] [Full Text] [Related]

  • 13. [The effect of methotrexate on intracellular nucleotide pools].
    Kawasaki H, Okubo T, Shimizu N, Komada M, Sako T, Hirota H, Noboru T, Kamiya H, Sakurai M, Izawa T.
    Gan To Kagaku Ryoho; 1985 Mar 01; 12(3 Pt 1):485-92. PubMed ID: 4039917
    [Abstract] [Full Text] [Related]

  • 14. Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture.
    Fairchild CR, Maybaum J, Straw JA.
    Cancer Chemother Pharmacol; 1988 Mar 01; 22(1):26-32. PubMed ID: 3396144
    [Abstract] [Full Text] [Related]

  • 15. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD, Akman SA, Schrecker AW, Bachur NR.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [Abstract] [Full Text] [Related]

  • 16. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS, Galivan J, Wright JE, Rosowsky A.
    Mol Pharmacol; 1994 Apr 01; 45(4):783-91. PubMed ID: 7514264
    [Abstract] [Full Text] [Related]

  • 17. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
    Park J, Franco RS, Augsburger JJ, Banerjee RK.
    Curr Eye Res; 2007 Apr 01; 32(7-8):659-67. PubMed ID: 17852190
    [Abstract] [Full Text] [Related]

  • 18. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
    Piper AA, Nott SE, Mackinnon WB, Tattersall MH.
    Cancer Res; 1983 Nov 01; 43(11):5101-5. PubMed ID: 6616448
    [Abstract] [Full Text] [Related]

  • 19. Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity.
    Johnson LF, Fuhrman CL, Abelson HT.
    Cancer Res; 1978 Aug 01; 38(8):2408-12. PubMed ID: 667839
    [Abstract] [Full Text] [Related]

  • 20. Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages.
    Bökkerink JP, De Abreu RA, Bakker MA, Hulscher TW, van Baal JM, Schretlen ED, De Bruijn CH.
    Biochem Pharmacol; 1988 Jun 15; 37(12):2329-38. PubMed ID: 2455520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.